To receive an accurate diagnosis for celiac disease, many patients have to eat gluten regularly before undergoing lab tests.

Researchers at the University of Cambridge are conducting groundbreaking research to better understand patient experiences of flares in autoimmune diseases.

Living with an autoimmune disease can be isolating. It’s often hard to find others who truly understand the challenges of navigating symptoms, treatments, and the emotional toll that comes with them.

It is well known that a combination of factors, such as genetics, environmental triggers, and possible hormonal influences, can lead to the development of autoimmune diseases. Recent studies show that those with endometriosis are at an increased risk of developing an array of autoimmune diseases, such as rheumatoid arthritis, celiac disease, multiple sclerosis, and psoriasis.

Clinical trials are essential in advancing medical knowledge and creating new treatments. By evaluating the safety and efficacy of new therapies, clinical trials can help determine which treatments work best and which ones need to be improved, ultimately improving patient outcomes.

A recent study published in The Lancet Rheumatology identifies a promising new blood biomarker that might be able to identify those at risk for severe scleroderma.

Drug repurposing is a relatively new concept; that is, it emerged in the early 2000s but garnered attention during the COVID-19 pandemic. The objective of drug repurposing is to speed up the drug discovery process by finding new uses for already existing drugs.

Sjögren's Awareness Month is a time to raise awareness about the complexity and underdiagnosis of Sjögren's disease.

The mystery of how autoimmune diseases come about continues to unfold as researchers learn more about the various immunological responses and triggers. Scientists at Washington University School of Medicine in St. Louis collaborated with the Perelman School of Medicine at the University of Pennsylvania to identify a protein that drives immune response and overactivity.

In England, individuals with MS will soon have access to a take-home pill to manage relapses, eliminating the need for hospital visits for injections or infusions.

March is not only Autoimmune Awareness Month but also Women's History Month! These two celebrations occurring at the same time should be no surprise, especially since women are at a higher risk of developing autoimmune diseases compared to men.

Individuals diagnosed with an autoimmune disease may have heard of “multiple autoimmune syndrome.” Multiple autoimmune syndrome (MAS) is defined as a patient having at least three autoimmune diseases.

Rare Disease Day, observed every February 28th, is dedicated to raising awareness about the challenges faced by individuals living with rare diseases.

Diversity isn't just a buzzword when researching autoimmune and rare diseases—it’s essential for better treatments and care. These conditions affect people from all backgrounds, but clinical trials often don’t reflect that diversity.

Current treatments for autoimmune diseases mostly consist of drugs that suppress the immune system and can lead to undesirable side effects. However, a new study shows that vagus nerve stimulation—which consists of tiny pulses of electricity that stimulate the vagus nerve—may offer an innovative way to replace drug treatments.

A study published by the Journal of Investigative Dermatology reveals a potential breakthrough treatment for those diagnosed with vitiligo.